Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-26

Clinical Trial Update: Testing if BCG (Bacille Calmette-Guérin) Vaccination Can Induce Innate Immune Training in Adult People Above 50 Years of Age in Guinea-Bissau [Phase 4]

View source ↗

Summary

Phase 4 trial assessing whether BCG vaccination can induce innate immune training in adults over 50 in Guinea-Bissau; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bacille Calmette-Guérin (BCG) vaccine (mycobacterium bovis BCG vaccine)

Snippet

Sponsor: Bandim Health Project | Conditions: Innate Immunity, Bacille Calmette-Guérin | Phase 4 | Status: COMPLETED